Histopathology and histomorphometry of umbilical cord blood vessels. Findings in normal and high risk pregnancies

Artery Research

Volumn 5, Issue 2, 2011, Pages 50-57

  Blanco, Manuel Vázquez ^a   Vega, Hilda Ruda ^a   Guerri Guttenberg, Roberto A ^b   Giuliano, Rodolfo ^a   Grana, Daniel R ^b   Azzato, Francisco ^b   Milei, José ^b  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Diabetes; Histomorphometry; Hypertension; PAI 1; Preeclampsia; TGF 1; Umbilical cord

Indexed keywords

PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIRTH WEIGHT; BLOOD VESSEL WALL; CONTROLLED STUDY; FEMALE; FETUS DISTRESS; HIGH RISK PREGNANCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC CHOLESTASIS; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; MORPHOMETRICS; NEWBORN; OBSTETRIC HEMORRHAGE; OLIGOHYDRAMNIOS; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; THROMBOSIS; UMBILICAL ARTERY; UMBILICAL CORD; UMBILICAL CORD BLOOD FLOW; UMBILICAL VEIN;

EID: 79956220084     PISSN: 18729312     EISSN: 18764401     Source Type: Journal    
DOI: 10.1016/j.artres.2011.02.001     Document Type: Article

References (26)

1. Stehbens W.E., Wakefield J.S., Gilbert-Barness E., Zuccollo J.M. Histopathology and ultrastructure of human umbilical blood vessels. Fetal Pediatr Pathol 2005, 24:297-315.
2. Benirschke K., Kaufmann P., Baergen R. Pathology of the human placenta 2006, Springer, New York. 5th ed.
3. Metzger B.E., Coustan D.M. Organizing committee. Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care 1998, 21(Suppl. 2):B161-B167.
4. Vega J.L., Puebla C., Vásquez R., Alarcón J., Pastor-Anglada M., et al. TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium. Cardiovasc Res 2009, 82:458-467.
5. Nanaev A.K., Kohnen G., Milovanov A.P., Domogatsky S.P., Kaufmann P. Stromal differentiation and architecture of the human umbilical cord. Placenta 1997, 18:53-64.
6. Pandolfi A., Cetrullo D., Polishuck R., Alberta M.M., Calafiore A., Pellegrini G., et al. Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Arterioscler Thromb Vasc Biol 2001, 21:1378-1382.
7. Sartori M.T., Serena A., Saggiorato G., Campei S., Faggian D., Pagnan A., et al. Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders. J Thromb Haemost 2008, 6:352-358.
8. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000, 183:S1-S22.
9. Riely C.A., Bacq Y. Intrahepatic cholestasis of pregnancy. Clin Liver Dis 2004, 8:167-176.
10. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999, 42:1309-1311.
11. Resnik R. Intrauterine growth restriction. Obstet Gynecol 2002, 99:490-496.
12. Locatelli A., Zagarella A., Toso L., Assi F., Ghidini A., Biffi A. Serial assessment of amniotic fluid index in uncomplicated term pregnancies: prognostic value of amniotic fluid reduction. J Matern Fetal Neonatal Med 2004, 15:233-236.
13. American College of Obstetricians and Gynecologists. Perinatal care at the threshold of viability. ACOG Practice Bulletin No. 38. Washington DC: American College of Obstetricians and Gynecologists; 2002.
14. Shepherd J.T. Bayliss response in the umbilical artery. Fed Proc 1968, 27:1408-1409.
15. MacKenna D., Summerour S.R., Villarreal F.J. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res 2000, 46:257-263.
16. Dyer D.C. Comparison of the constricting actions produced by serotonin and prostaglandins on isolated sheep umbilical arteries and veins. Gynecol Invest 1970, 1:204-209.
17. Harold J.G., Siegel R.J., Fitzgerald G.A., Satoh P., Fishbein M.C. Differential prostaglandin production by human umbilical vasculature. Arch Pathol Lab Med 1988, 112:43-46.
18. Mildenberger E., Biesel B., Siegel G., Versmold H.T. Nitric oxide and endothelin in oxygen-dependent regulation of vascular tone of human umbilical vein. Am J Physiol Heart Circ Physiol 2003, 285:H1730-H1737.
19. Giles W., O'Callaghan S., Read M., Gude N., King R., Brennecke S. Placental nitric oxide synthase activity and abnormal umbilical artery flow velocity waveforms. Obstet Gynecol 1997, 89:49-52.
20. Salas S.P., Power R.F., Singleton A., Wharton J., Polak J.M., Brown J. Heterogeneous binding sites for a-atrial natriuretic peptide in human umbilical cord and placenta. Am J Physiol 1991, 261:R633-R638.
21. Raio L., Ghezzi F., Di Naro E., Gomez R., Franchi M., Mazor M., et al. Sonographic measurement of the umbilical cord and fetal anthropometric parameters. Eur J Obstet Gynecol Reprod Biol 1999, 83:131-135.
22. Barker D.J.P. In utero programming of chronic disease. Clin Sci (London) 1998, 95:115-128.
23. Gluckman P.D., Hanson M.A. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res 2004, 56:311-317.
24. Gassner C.B., Paul R.H. Laceration of umbilical cord vessels secondary to amniocentesis. Obstet Gynecol 1976, 48:627-630.
25. Singhal A., Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis?. Lancet 2004, 363:1642-1645.
26. Bateson P., Barker D., Clutton-Brock T., Deb D., D'Udine B., Foley R.A., et al. Developmental plasticity and human health. Nature 2004, 430:419-421.